SK283442B6 - Farmaceutický prípravok na orálne podanie - Google Patents

Farmaceutický prípravok na orálne podanie Download PDF

Info

Publication number
SK283442B6
SK283442B6 SK1298-95A SK129895A SK283442B6 SK 283442 B6 SK283442 B6 SK 283442B6 SK 129895 A SK129895 A SK 129895A SK 283442 B6 SK283442 B6 SK 283442B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical preparation
cyclosporin
hlb value
gelucir
component
Prior art date
Application number
SK1298-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK129895A3 (en
Inventor
Monika Petszulat
Klaus Neuer
Hatto Walch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25925049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK283442(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4412201A external-priority patent/DE4412201A1/de
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK129895A3 publication Critical patent/SK129895A3/sk
Publication of SK283442B6 publication Critical patent/SK283442B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SK1298-95A 1993-04-20 1994-04-20 Farmaceutický prípravok na orálne podanie SK283442B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4312728 1993-04-20
DE4412201A DE4412201A1 (de) 1993-04-20 1994-04-08 Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
PCT/EP1994/001228 WO1994023733A1 (de) 1993-04-20 1994-04-20 Neue pharmazeutische zubereitungen zur oralen verabreichung enthaltend cyclosporin

Publications (2)

Publication Number Publication Date
SK129895A3 SK129895A3 (en) 1997-02-05
SK283442B6 true SK283442B6 (sk) 2003-07-01

Family

ID=25925049

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1298-95A SK283442B6 (sk) 1993-04-20 1994-04-20 Farmaceutický prípravok na orálne podanie

Country Status (13)

Country Link
EP (1) EP0697881B2 (cs)
JP (2) JP3862273B2 (cs)
AT (1) ATE218878T1 (cs)
CA (1) CA2161143A1 (cs)
CZ (1) CZ291237B6 (cs)
DK (1) DK0697881T3 (cs)
ES (1) ES2178653T3 (cs)
FI (1) FI116120B (cs)
HU (1) HUT72738A (cs)
NO (1) NO321076B1 (cs)
PT (1) PT697881E (cs)
SK (1) SK283442B6 (cs)
WO (1) WO1994023733A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
GB2355195B (en) * 1997-01-30 2001-09-12 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
ES2266564T3 (es) 2001-10-19 2007-03-01 Isotechnika Inc. Sintesis de analogos de cicloporinas.
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US7682433B2 (en) 2007-05-11 2010-03-23 Canon Kabushiki Kaisha Ink set, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) † 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3580717D1 (de) * 1984-08-02 1991-01-10 Sandoz Ag Pharmazeutische anwendung von (nva)2-cyclosporine.
AU609242B2 (en) † 1988-01-29 1991-04-26 Novartis Ag Cyclosporin compositions
GB2222770B (en) † 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB2230440B (en) † 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms

Also Published As

Publication number Publication date
ES2178653T3 (es) 2003-01-01
EP0697881B2 (de) 2009-05-06
EP0697881A1 (de) 1996-02-28
CA2161143A1 (en) 1994-10-27
FI116120B (fi) 2005-09-30
FI954986A0 (fi) 1995-10-19
FI954986A (fi) 1995-10-19
WO1994023733A1 (de) 1994-10-27
ATE218878T1 (de) 2002-06-15
HU9503019D0 (en) 1995-12-28
CZ291237B6 (cs) 2003-01-15
DK0697881T3 (da) 2002-10-07
HUT72738A (en) 1996-05-28
PT697881E (pt) 2002-10-31
CZ272995A3 (en) 1996-02-14
NO954152L (no) 1995-10-18
EP0697881B1 (de) 2002-06-12
JP3862273B2 (ja) 2006-12-27
JPH08508984A (ja) 1996-09-24
JP2006206615A (ja) 2006-08-10
NO954152D0 (no) 1995-10-18
NO321076B1 (no) 2006-03-13
SK129895A3 (en) 1997-02-05

Similar Documents

Publication Publication Date Title
RU2257917C2 (ru) Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
EP0710104B1 (de) Pharmazeutische präparate für schwerlösliche wirkstoffe
JP2006206615A (ja) 経口投与用シクロスポリン含有新規製剤
EP1039893B1 (en) Pharmaceutical compositions containing an omega-3 fatty acid oil
SK285809B6 (sk) Mikroemulzný prekoncentrát cyklosporínu alebo makrolidu
AU765935B2 (en) Substantially oil-free cyclosporin compositions
SK13192000A3 (sk) Kompozícia vo forme mikroemulzného prekoncentrátu obsahujúca cyklosporín a jej použitie
US20040018992A1 (en) Pharmaceutical compositions for sparingly soluble therapeutic agents
KR100471680B1 (ko) 사이클로스포린제제
AU2002361701A1 (en) Pharmaceutical compositons of orally active taxane derivatives having enhanced bioavailability
US20020049158A1 (en) Oral drug composition containing a verapamil derivative as a drug-absorption promotor
GB2355656A (en) Preparation of gel emulsions of hydrophobic pharmaceuticals
EP0657164A1 (en) Pharmaceutical compositions containing staurosphorine derivatives
SK283216B6 (sk) Prípravok obsahujúci cyklosporín a spôsob jeho prípravy
US20020107183A1 (en) Pharmaceutical preparations comprising cyclosporin for oral administration
CA2355271A1 (en) Cyclosporin solution
KR0173349B1 (ko) 사이클로스포린-함유 고체 분산체 조성물
US6979672B2 (en) Cyclosporin-based pharmaceutical compositions
SK123299A3 (en) Pharmaceutical compositions containing cyclosporin

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100420